(Q36559288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Spalletta G

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Ciaramella A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Bria P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Caltagirone C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Robinson RG

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

8 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

984-991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894392%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001879

28 December 2019

exact match

0 references

cites work

Comparison of cortical and subcortical lesions in the production of poststroke mood disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Major depression in stroke patients. A 3-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Lesion location and poststroke depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Depression in acute and chronic aphasia: symptoms, pathoanatomical-clinical correlations and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Depressive changes in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Poststroke depression and lesion location revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Magnetic resonance imaging correlates of depression after ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Alexithymic features in stroke: effects of laterality and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Response of emotional unawareness after stroke to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Lesion location and poststroke depression: systematic review of the methodological limitations in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Reversible changes in the activities and amounts of tyrosine hydroxylase in dopamine neurons of the substantia nigra in response to axonal injury as studied by immunochemical and immunocytochemical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Inflammatory mediators and stroke: new opportunities for novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Inflammation and infections as risk factors for ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Site-specific actions of interleukin-1 on excitotoxic cell death in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Interleukin-1 and neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Interleukin-1 gene cluster polymorphisms in cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Cytokines and acute neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Increased cytokine release from peripheral blood cells after acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Early TNF-alpha levels correlate with ischaemic stroke severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

C-reactive protein and outcome after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

C-reactive protein in ischemic stroke: an independent prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Multiple levels of regulation of the interleukin-6 system in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Intrathecal release of pro- and anti-inflammatory cytokines during stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Monocyte function and plasma levels of interleukin-8 in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

IL-18: a key player in neuroinflammation and neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Cloning of rat brain interleukin-18 cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Cultures of astrocytes and microglia express interleukin 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Interleukin-18 induces expression and release of cytokines from murine glial cells: interactions with interleukin-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

No role for interleukin-18 in acute murine stroke-induced brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Interleukin-18 in acute ischaemic stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Cytokines and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Cytokine-induced sickness behavior: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Cerebrospinal cytokine levels in patients with acute depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Raised levels of plasma interleukin-1beta in major and postviral depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Inflammatory Proteins and Depression in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Interleukin-18 and CD30 serum levels in patients with moderate-severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Plasma interleukin-18 levels in patients with psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Increased serum interleukin-1-receptor-antagonist concentrations in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Association of depression with 10-year poststroke mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Effects of antidepressants on cytokine production and actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

Psychiatric considerations of cerebral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Mood change following left hemispheric brain injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Lateralization of dementia of depression in stroke patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Interleukin-6 and interleukin-1 receptor antagonist in acute stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Proinflammatory cytokines and early neurological worsening in ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Increased cytokine release by leucocytes in survivors of stroke at young age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Interleukin-18 involvement in hypoxic-ischemic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Interleukin-1 beta production in dysthymia before and after pharmacotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Cytokine production and serum proteins in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Longitudinal assessment of depression and cognitive impairment following stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021

Antidepressant therapy and C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001879

7 January 2021